Daewoong Pharmaceutical hosted a symposium titled ‘NABOTA Sparkling Night’ in Thailand

Daewoong Pharmaceutical hosted a symposium titled ‘NABOTA Sparkling Night’ in Thailand ​- Presented the competitiveness of botulinum toxin manufactured by Daewoong Pharmaceutical, the first Asian Botulinum Toxin approved by the U.S. FDA. - Shared the significance of FDA-approval and the latest treatment trends using Nabota for about 80 specialists of cosmetic surgery in Thailand. Daewoong Pharmaceutical (CEO Sengho Jeon) announced that they successfully hosted ‘NABOTA Sparkling Night’ at Hyatt Regency Bangkok, Thailand on the 26th for the independently developed Botulinum Toxin called ‘Nabota.’ The symposium was held to celebrate the U.S. FDA-approval of botulinum toxin manufactured by Daewoong Pharmaceutical and invited about 80 specialists of cosmetic surgery in Thailand.  It is even more significant because Thailand is the first overseas country where Nabota was launched in 2014. The speakers were Professor Rungsima, a local dermatologist in Thailand, (Siriraj Hospital) and Dr. Sang Ho Shin, a specialist of cosmetic surgery from Korea (Christmas Cosmetic Surgery Clinic) and they spoke about the significance of the U.S. FDA-approval and how to choose the right Botulinum Toxin among other products.  Professor Rungsima and Dr. Shin explained that the U.S. FDA approval is the major representation of product quality and safety and has a significant influence on the practitioners’ choices. Dr. Sang Ho Shin presented the clinical results of Nabota.  “Nabota has proven non-inferiority in terms of improvement of frown lines and safety through a comparative clinical study with Allergan’s Botox,” he remarked.  “It is a great benefit for the physicians to be able to recommend a product with quality that compares to that of Botox for a more reasonable price.” The local practitioners of Thailand who attended the symposium were highly interested in the latest medical trends in relation to Nabota.  “It was impressive that as Korea has become a super-aged society, the industries related to anti-aging are quickly rising and there are many various well-aging techniques developing for the aged patients in the beauty industry,” said Dr. Kriangkrai Aow–Udomphan of Dio Clinic in Thailand.  “I believe that these latest trends of Korea would be adaptable to the Thai market in the future.” “It is a great pleasure for us to share the growth of Nabota into a global brand in just 5 years since Nabota was introduced to Thailand in 2014,” said Director Seungsoo Park of Daewoong Pharmaceutical’s Nabota Division.  “We are planning to announce the excellence of Nabota to the medical practitioners all around the world, including Korea and Thailand, and solidify our ground as a global brand.” #  #  # [Photo] Daewoong Pharmaceutical successfully hosted the ‘NABOTA Sparkling Night’ symposium at at Hyatt Regency Bangkok, Thailand on the 26th.

The release as fetched from its publisher. daewoong.co.kr ↗